Nova Patents
AT248922T

Hormone analogs with multiple ctp extensions.

Abstract

The invention describes a peptide and pharmaceutical PROTEIN WITH PROLONGED HALF-LIVES. The peptide MODIFIED AND proteins of the invention contain at least two EXTENSIONS IN TANDEM IN ITS TERMS-C comprising a carboxylated TERMINAL PORTION OF HUMAN CROIONICA gonadotropin. THESE "CTP units" consisting essentially STREAMS-BETA HCG from position 145 to position 112.118 OR CHANGES IN CONSERVATIVE.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

147 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
77126291United States of AmericaA
9208424United States of AmericaW

Members147

Family members, oldest first
DocumentOfficeKind
CA2053864A1CanadaA1
WO9009800A1World Intellectual Property Organization (WIPO)A1
AU5332790AAustraliaA
EP0461200A1European Patent Office (EPO)A1
JPH04503606AJapanA
EP0461200A4European Patent Office (EPO)A4
US5177193AUnited States of AmericaA
CA2120358A1CanadaA1
WO9306844A1World Intellectual Property Organization (WIPO)A1
AU2864892AAustraliaA
NO941186D0NorwayD0
NO941186LNorwayL
AU648020B2AustraliaB2
FI941500AFinlandA
EP0607297A1European Patent Office (EPO)A1
US5338835AUnited States of AmericaA
AU6747494AAustraliaA
CA2160800A1CanadaA1
WO9424148A1World Intellectual Property Organization (WIPO)A1
AU6633194AAustraliaA
ZA942729BSouth AfricaB
JPH07502166AJapanA
US5405945AUnited States of AmericaA
CA2183564A1CanadaA1
CA2219948A1CanadaA1
WO9522340A1World Intellectual Property Organization (WIPO)A1
AU1878795AAustraliaA
NO954188D0NorwayD0
EP0607297A4European Patent Office (EPO)A4
FI954978AFinlandA
IL114859D0IsraelD0
NO954188LNorwayL
EP0695307A1European Patent Office (EPO)A1
CA2173750A1CanadaA1
WO9605224A1World Intellectual Property Organization (WIPO)A1
AU3206695AAustraliaA
AU667489B2AustraliaB2
FI961600AFinlandA
NO961433D0NorwayD0
NO961433LNorwayL
TR199500991A2TürkiyeA2
AU670510B2AustraliaB2
EP0725795A1European Patent Office (EPO)A1
EP0695307A4European Patent Office (EPO)A4
CN1131952AChinaA
JPH08509218AJapanA
KR960704932ARepublic of KoreaA
US5585345AUnited States of AmericaA
EP0751782A1European Patent Office (EPO)A1
AU6581996AAustraliaA
EP0461200B1European Patent Office (EPO)B1
AT148171TAustriaT
ATE148171T1AustriaT1
DE69029799D1GermanyD1
DK0461200T3DenmarkT3
ES2098261T3SpainT3
DE69029799T2GermanyT2
HUT75900AHungaryA
MX9601320AMexicoA
JPH09505741AJapanA
BR9506313ABrazilA
JPH09509418AJapanA
US5705478AUnited States of AmericaA
NZ265529ANew ZealandA
US5712122AUnited States of AmericaA
AU687053B2AustraliaB2
EP0725795A4European Patent Office (EPO)A4
EP0839831A2European Patent Office (EPO)A2
US5759818AUnited States of AmericaA
AU695111B2AustraliaB2
US5792460AUnited States of AmericaA
AU697899B2AustraliaB2
AU703718B2AustraliaB2
JPH11263799AJapanA
US5958737AUnited States of AmericaA
EP0839831A3European Patent Office (EPO)A3
EP0695307B1European Patent Office (EPO)B1
AT187740TAustriaT
ATE187740T1AustriaT1
DE69422169D1GermanyD1
US6028177AUnited States of AmericaA
ES2141229T3SpainT3
IN183927BIndiaB
JP3045539B2JapanB2
PT695307EPortugalE
GR3032775T3GreeceT3
EP0751782A4European Patent Office (EPO)A4
KR100281811B1Republic of KoreaB1
US6225449B1United States of AmericaB1
US6238890B1United States of AmericaB1
US6242580B1United States of AmericaB1
US2001007757A1United States of AmericaA1
US6306654B1United States of AmericaB1
CA2053864CCanadaC
JP2002060347AJapanA
EP0607297B1European Patent Office (EPO)B1
AT248922TThis recordAustriaT
ATE248922T1AustriaT1
RU2213099C2Russian FederationC2
DE69233188D1GermanyD1
Showing 100 of 147